3188
K.A. Clayton et al. / Tetrahedron 64 (2008) 3183e3189
1
appearance: yellow solid; H NMR (300 MHz, CD3COCD3)
4.4.1.4. Ethyl 30-(400-bromophenyl)-40,60-dimethoxyindol-70-yl-
2-(O-2,4-dinitrophenoxyimino)acetate (1b). Yield: 0.09 g,
d 1.35 (t, 3H, J¼6.8 Hz, CH3), 2.13 (s, 3H, 400-Me), 3.80 (br s,
1
59%, mp 197e198 ꢃC, appearance: orange solid; H NMR
6H, OMe), 4.45 (q, 2H, J¼6.8 Hz, CH2), 6.35 (s, 1H, H5 ),
0
0
6.90e7.30 (m, 5H, H2 , H2 , H3 ), 10.42 (br s, 1H, NH).
00
00
(300 MHz, CDCl3) d 1.45 (t, 3H, J¼7.2 Hz, CH3), 3.91 (s,
3H, OMe), 3.92 (s, 3H, OMe), 4.53 (q, 2H, J¼7.2 Hz, CH2),
0
0
6.28 (s, 1H, H5 ), 7.14 (d, 1H, J¼7.2 Hz, H2 ), 7.43 (d, 2H,
4.4.1.8. Ethyl 40,60-dimethoxy-30-(400-methylphenyl)indol-70-yl-
00
00
J¼8.3 Hz, H2 ), 7.51 (d, 2H, J¼8.3 Hz, H3 ), 7.86 (d, 1H,
2-(O-2,4-dinitrophenoxyimino)acetate (1e). Yield: 0.04 g,
1
000
000
J¼9.0 Hz, H6 ), 8.49 (dd, 1H, J¼2.6, 9.0 Hz, H5 ), 8.91 (d,
74%, mp 170e171 ꢃC, appearance: yellow-orange solid; H
1H, J¼2.6 Hz, H3 ), 9.82 (br s, 1H, NH); 13C NMR
NMR (300 MHz, CDCl3) d 1.43 (t, 3H, J¼7.2 Hz, CH3),
000
(75.5 MHz, CDCl3) d 13.3 (CH3), 54.8, 57.0 (OMe), 61.5
2.41 (s, 3H, 400-Me), 3.91 (s, 3H, OMe), 3.92 (s, 3H, OMe),
0
0
0
(CH2), 89.4 (C5 ) 93.7 (C7 ), 110.9 (C3a ), 117.4 (C6 ), 117.7
000
0
4.31 (q, 2H, J¼7.2 Hz, CH2), 6.26 (s, 1H, H5 ), 7.12 (s, 1H,
0
(C3 ), 121.2 (C3 ), 122.8 (C2 ), 127.2 (C2 ), 129.2 (C5 ),
00
131.0 (C3 ), 134.3 (C4 ), 134.7 (C1 ), 135.2 (C7a ), 136.5
000
0
00
000
0
00
H2 ), 7.16 (d, 2H, J¼7.9 Hz, H3 ), 7.46 (d, 2H, J¼7.9 Hz,
00
00
0
0
0
0
0
0
H2 ), 7.87 (d, 1H, J¼9.4 Hz, H6 ), 8.41 (dd, 1H, J¼2.6,
13
000
000
000
0
0
0
0
0
0
0
0
(C2 ), 141.8 (C4 ), 155.6 (C1 ), 159.0 (C4 ), 159.7 (C6 ),
160.1 (C]N), 161.6 (OCO); nmax 3733, 1733, 1716,
1657 cmꢀ1; lmax (CHCl3) 376 nm (3 8400 cmꢀ1 Mꢀ1), 334
(10,000), 256 (15,000); m/z (ESI) 613/615 ([MþH], 8%),
429/431 (100), 368 (22), 338 (10). Found: C, 44.0; H, 3.2;
N, 8.0. Calcd for C26H21BrN4O9$1CHCl3: C, 44.3; H, 3.0;
N, 7.6.
9.4 Hz, H5 ), 8.72 (d, 1H, J¼2.6 Hz, H3 ), 9.75 (br s, 1H,
NH); C NMR (75.5 MHz, CDCl3) d 14.0 (CH3), 21.1 (400-
0
0
Me), 55.3, 57.4 (OMe), 62.3 (CH2), 85.4 (C5 ) 88.7 (C7 ),
000
103.0 (C3a ), 116.5 (C3 ), 119.7 (C6 ), 121.4 (C3 ), 122.0
00
(C2 ), 127.7 (C5 ), 128.4 (C2 ), 129.2 (C3 ), 129.4 (C1 ),
000
132.1 (C4 ), 135.8 (C2 ), 136.1 (C7a ), 141.0 (C4 ), 156.7
(C6 ), 159.2 (C1 ), 160.0 (C4 ), 166.9 (C]N), 169.9 (OCO);
nmax 3776, 3684, 3621, 1708, 1598 cmꢀ1; lmax (CHCl3)
386 nm (3 1400 cmꢀ1 Mꢀ1), 329 (2800), 243 (4700). HRMS
found: 549.1625. Calcd for C27H25N4O9 ([MþH]þ):
549.1616.
0
0
000
0
000
00
00
00
000
0
0
000
0
4.4.1.5. Ethyl 30-phenyl-40,60-dimethoxyindol-70-yl-2-(hydroxy-
imino)acetate (7d). Ethyl 2-(30-phenyl-40,60-dimethoxyindol-
70-yl)glyoxylate 6d: 0.27 g, 0.75 mmol; appearance: yellow
solid; 1H NMR (300 MHz, CD3COCD3) d 1.36 (t, 3H,
J¼7.5 Hz, CH3), 3.85 (br s, 6H, OMe), 4.36 (q, 2H,
4.5. Preparation of pyrrolo[3,2,1-hi]indazoles
0
0
J¼7.5 Hz, CH2), 6.41 (br s, 1H, H5 ), 7.17 (br s, 1H, H2 ),
00
00
00
7.25e7.38 (br s, 3H, H3 , H4 ), 7.56 (d, 2H, J¼7.1 Hz, H2 ),
4.5.1. General preparation of the tricycles 2
11.29 (br s, 1H, NH); 13C NMR (75.5 MHz, CD3COCD3)
The appropriately substituted cyclisation precursor 1
(1 mol equiv) and triethylamine (10 mol equiv) in dry tetrahy-
drofuran (42 L per mole of cyclisation precursor 1) were
heated at reflux until TLC analysis showed consumption of
the starting material. The solvent was then removed in vacuo,
and the solid dissolved in dichloromethane before extracting
with water, followed by 2 M sodium hydroxide, 2 M hydro-
chloric acid and finally 2 M sodium hydroxide again. Each ex-
traction was performed until the aqueous layer was no longer
coloured. The organic layer was dried over magnesium sulfate
and the solvent removed in vacuo. The remaining solid was
then purified using preparative TLC (methanol/chloroform,
1:100). Due to the small amounts of the tricycles 2 produced,
they were characterised using NMR spectroscopy and HRMS.
0
d 13.4 (CH3), 54.5, 57.0 (OMe), 61.2 (CH2), 89.0 (C5 ), 96.6
00
(C7 ), 110.9 (C3 ), 122.0 (C2 ), 125.4 (C2 ), 129.2 (C3 ),
00
132.7 (C4 ), 135.9 (C1 ), 135.9 (C7a , C3a ), 156.0 (C4 ),
0
156.9 (C6 ), 165.2 (C]N), 166.1 (OCO).
0
0
0
00
00
0
0
0
4.4.1.6. Ethyl 30-phenyl-40,60-dimethoxyindol-70-yl-2-(O-2,4-di-
nitrophenoxyimino)acetate (1d). Yield: 0.15 g, 37%, mp 192e
193 ꢃC, appearance: yellow solid; 1H NMR (300 MHz,
CDCl3) d 1.43 (t, 3H, J¼7.2 Hz, CH3), 3.90 (s, 3H, OMe),
3.92 (s, 3H, OMe), 4.53 (q, 2H, J¼7.2 Hz, CH2), 6.27 (s,
0
0
00
00
1H, H5 ), 6.91 (s, 1H, H2 ), 7.15e7.50 (m, 5H, H2 , H3 ,
00
000
H4 ), 7.88 (d, 1H, J¼9.4 Hz, H6 ), 8.50 (dd, 1H, J¼2.6,
000
000
9.4 Hz, H5 ), 8.92 (d, 1H, J¼2.6 Hz, H3 ), 9.81 (br s, 1H,
NH); 13C NMR (75.5 MHz, CD3COCD3) d 13.4 (CH3),
4.5.1.1. Ethyl 1-(40-cyanophenyl)-6,8-dimethoxypyrazolo[4,5,
1-hi]indole-5-carboxylate (2a). Ethyl 30-(400-cyanophenyl)-
40,60-dimethoxyindol-70-yl-2-(O-2,4-dinitrophenoxyimino)ace-
tate 1a: 0.098 g, 0.175 mmol, yield: 0.030 g, 45%, appearance:
yellow solid; 1H NMR (300 MHz, CDCl3) d 1.39 (t, 3H,
J¼7.2 Hz, CH3), 3.88 (s, 3H, OMe), 3.93 (s, 3H, OMe),
4.35 (q, 2H, J¼7.2 Hz, CH2), 6.55 (s, 1H, H7), 7.72 (d, 2H,
0
54.8, 57.2 (OMe), 61.7 (CH2), 89.5 (C5 ) 93.6 (C7 ), 111.2
0
0
000
0
000
0
(C3a ), 117.8 (C6 ), 118.8 (C3 ), 121.1 (C3 ), 122.7 (C2 ),
00
00
00
125.7 (C4 ), 127.3 (C3 ), 129.4 (C2 ), 129.8 (C5 ), 135.2
000
00
(C1 ), 135.6 (C7a ), 135.6 (C2 ), 141.7 (C4 ), 156.1 (C1 ),
0
000
000
000
0
0
159.4 (C4 ), 159.9 (C6 ), 160.0 (C]N), 161.5 (OCO); nmax
3440, 1732, 1600 cmꢀ1
lmax (CHCl3) 395 nm (3
;
8500 cmꢀ1 Mꢀ1), 334 (13,000), 258 (17,000); m/z (ESI) 535
([MþH], 8%), 385 (27), 252 (100), 280 (24). Found: C,
38.7; H, 3.1; N, 6.7. Calcd for C26H22N4O9$3CHCl3: C,
39.0; H, 2.8; N, 6.3.
0
J¼8.7 Hz, H3 ), 7.74 (s, 1H, H2), 7.87 (d, 2H, J¼8.7 Hz,
0
H2 ); nmax (CHCl3) 3687, 3614, 1814, 1794, 1713, 1647,
1602 cmꢀ1. HRMS found: 376.1303. Calcd for C21H18N3O4
([MþH]þ): 376.1297.
4.4.1.7. Ethyl 40,60-dimethoxy-30-(400-methylphenyl)indol-70-yl-
2-(hydroxyimino)acetate (7e). Ethyl 2-[40,60-dimethoxy-30-
(400-methylphenyl)indol-70-yl]glyoxylate 6e: 0.02 g, 0.07 mmol,
4.5.1.2. Ethyl 1-(40-bromophenyl)-6,8-dimethoxypyrazolo[4,5,1-
hi]indole-5-carboxylate (2b). Ethyl 30-(400-bromophenyl)-